Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 5/20 | 0.64 |
| ▸ | CHUK | O15111 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20327619 | 0.93 | KIF11 (0.59) | KIF11CHUKLMNAHPGDACHE | |
| SCHEMBL6979361 | 0.90 | KIF11 (0.55) | KIF11CHUKLMNAHPGDACHE | |
| SCHEMBL6007682 | 0.90 | KIF11 (0.62) | KIF11LMNAHPGDPIM3RXFP1 | |
| SCHEMBL10141055 | 0.86 | KIF11 (0.75) | KIF11LMNAHPGDACHERXFP1 | |
| SCHEMBL16552984 | 0.86 | CHUK (0.61) | KIF11CHUKLMNAHPGDPIM3 | |
| SCHEMBL29726991 | 0.86 | KIF11 (0.75) | KIF11LMNAHPGDACHERXFP1 | |
| SCHEMBL29764121 | 0.86 | CHUK (0.61) | KIF11CHUKLMNAHPGDPIM3 | |
| SCHEMBL13828017 | 0.82 | KIF11 (0.72) | KIF11LMNAACHEPIM3RXFP1 | |
| SCHEMBL18830699 | 0.82 | CHUK (0.60) | CHUKLMNAHPGDPIM3RXFP1 | |
| SCHEMBL29366993 | 0.82 | CHUK (0.64) | CHUKLMNAHPGDPIM3RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807654-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and diagnostic composition including organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20230138421-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138421-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD2, OCIAD1, OXER1 | KIF11 2834/4885CHUK 4188/4885LMNA 4732/4885 |
| US-11807654-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and diagnostic composition including organometallic compound | L1CAM, FOXM1, MEN1 | KIF11 487/4885CHUK 3216/4885LMNA 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.